Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090850868> ?p ?o ?g. }
- W2090850868 endingPage "e7849" @default.
- W2090850868 startingPage "e7849" @default.
- W2090850868 abstract "Objective RTS,S, a candidate vaccine for malaria, is a recombinant protein expressed in yeast containing part of the circumsporozoite protein (CSP) sequence of 3D7 strain of Plasmodium falciparum linked to the hepatitis B surface antigen in a hybrid protein. The RTS,S antigen is formulated with GSK Biologicals' proprietary Adjuvant Systems AS02A or AS01B. A recent trial of the RTS,S/AS02A and RTS,S/AS01B vaccines evaluated safety, immunogenicity and impact on the development of parasitemia of the two formulations. Parasite isolates from this study were used to determine the molecular impact of RTS,S/AS02A and RTS,S/AS01B on the multiplicity of infection (MOI) and the csp allelic characteristics of subsequent parasitemias. Design The distribution of csp sequences and the MOI of the infecting strains were examined at baseline and in break-through infections from vaccinated individuals and from those receiving a non-malarial vaccine. Setting The study was conducted in Kombewa District, western Kenya. Participants Semi-immune adults from the three study arms provided isolates at baseline and during break-through infections. Outcome Parasite isolates used for determining MOI and divergence of csp T cell–epitopes were 191 at baseline and 87 from break-through infections. Results Grouping recipients of RTS,S/AS01A and RTS,S/AS02B together, vaccine recipients identified as parasite-positive by microscopy contained significantly fewer parasite genotypes than recipients of the rabies vaccine comparator (median in pooled RTS,S groups: 3 versus 4 in controls, P = 0.0313). When analyzed separately, parasitaemic individuals in the RTS,S/AS01B group, but not the RTS,S/AS02A group, were found to have significantly fewer genotypes than the comparator group. Two individual amino acids found in the vaccine construct (Q339 in Th2R and D371 in Th3R) were observed to differ in incidence between vaccine and comparator groups but in different directions; parasites harboring Q339 were less common among pooled RTS,S/AS vaccine recipients than among recipients of rabies vaccine, whereas parasites with D371 were more common among the RTS,S/AS groups. Conclusions It is concluded that both RTS,S/AS vaccines reduce multiplicity of infection. Our results do not support the hypothesis that RTS,S/AS vaccines elicit preferential effects against pfcsp alleles with sequence similarity to the 3D7 pfcsp sequence employed in the vaccine construct." @default.
- W2090850868 created "2016-06-24" @default.
- W2090850868 creator A5013809378 @default.
- W2090850868 creator A5015438763 @default.
- W2090850868 creator A5016959845 @default.
- W2090850868 creator A5020494903 @default.
- W2090850868 creator A5042257591 @default.
- W2090850868 creator A5044909638 @default.
- W2090850868 creator A5057250881 @default.
- W2090850868 creator A5064101606 @default.
- W2090850868 creator A5064528399 @default.
- W2090850868 creator A5076883842 @default.
- W2090850868 creator A5077528263 @default.
- W2090850868 creator A5080329476 @default.
- W2090850868 creator A5088287870 @default.
- W2090850868 date "2009-11-17" @default.
- W2090850868 modified "2023-10-14" @default.
- W2090850868 title "Impact of RTS,S/AS02A and RTS,S/AS01B on Genotypes of P. falciparum in Adults Participating in a Malaria Vaccine Clinical Trial" @default.
- W2090850868 cites W1889158463 @default.
- W2090850868 cites W1947327942 @default.
- W2090850868 cites W1966834016 @default.
- W2090850868 cites W1974245401 @default.
- W2090850868 cites W1990389546 @default.
- W2090850868 cites W2017379208 @default.
- W2090850868 cites W2027697581 @default.
- W2090850868 cites W2038910210 @default.
- W2090850868 cites W2046400301 @default.
- W2090850868 cites W2054582078 @default.
- W2090850868 cites W2061658473 @default.
- W2090850868 cites W2063755565 @default.
- W2090850868 cites W2067329114 @default.
- W2090850868 cites W2070633997 @default.
- W2090850868 cites W2071610307 @default.
- W2090850868 cites W2089006774 @default.
- W2090850868 cites W2095901889 @default.
- W2090850868 cites W2100923855 @default.
- W2090850868 cites W2107181087 @default.
- W2090850868 cites W2108045285 @default.
- W2090850868 cites W2117658969 @default.
- W2090850868 cites W2124892357 @default.
- W2090850868 cites W2125596172 @default.
- W2090850868 cites W2127104623 @default.
- W2090850868 cites W2139533311 @default.
- W2090850868 cites W2147645145 @default.
- W2090850868 cites W2155144810 @default.
- W2090850868 cites W2163861382 @default.
- W2090850868 cites W2340524139 @default.
- W2090850868 doi "https://doi.org/10.1371/journal.pone.0007849" @default.
- W2090850868 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2773849" @default.
- W2090850868 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19924281" @default.
- W2090850868 hasPublicationYear "2009" @default.
- W2090850868 type Work @default.
- W2090850868 sameAs 2090850868 @default.
- W2090850868 citedByCount "51" @default.
- W2090850868 countsByYear W20908508682012 @default.
- W2090850868 countsByYear W20908508682013 @default.
- W2090850868 countsByYear W20908508682014 @default.
- W2090850868 countsByYear W20908508682015 @default.
- W2090850868 countsByYear W20908508682016 @default.
- W2090850868 countsByYear W20908508682017 @default.
- W2090850868 countsByYear W20908508682018 @default.
- W2090850868 countsByYear W20908508682019 @default.
- W2090850868 countsByYear W20908508682020 @default.
- W2090850868 countsByYear W20908508682021 @default.
- W2090850868 countsByYear W20908508682022 @default.
- W2090850868 countsByYear W20908508682023 @default.
- W2090850868 crossrefType "journal-article" @default.
- W2090850868 hasAuthorship W2090850868A5013809378 @default.
- W2090850868 hasAuthorship W2090850868A5015438763 @default.
- W2090850868 hasAuthorship W2090850868A5016959845 @default.
- W2090850868 hasAuthorship W2090850868A5020494903 @default.
- W2090850868 hasAuthorship W2090850868A5042257591 @default.
- W2090850868 hasAuthorship W2090850868A5044909638 @default.
- W2090850868 hasAuthorship W2090850868A5057250881 @default.
- W2090850868 hasAuthorship W2090850868A5064101606 @default.
- W2090850868 hasAuthorship W2090850868A5064528399 @default.
- W2090850868 hasAuthorship W2090850868A5076883842 @default.
- W2090850868 hasAuthorship W2090850868A5077528263 @default.
- W2090850868 hasAuthorship W2090850868A5080329476 @default.
- W2090850868 hasAuthorship W2090850868A5088287870 @default.
- W2090850868 hasBestOaLocation W20908508681 @default.
- W2090850868 hasConcept C104317684 @default.
- W2090850868 hasConcept C135763542 @default.
- W2090850868 hasConcept C147483822 @default.
- W2090850868 hasConcept C159047783 @default.
- W2090850868 hasConcept C203014093 @default.
- W2090850868 hasConcept C203233990 @default.
- W2090850868 hasConcept C22070199 @default.
- W2090850868 hasConcept C2522874641 @default.
- W2090850868 hasConcept C2775867548 @default.
- W2090850868 hasConcept C2778048844 @default.
- W2090850868 hasConcept C2778371730 @default.
- W2090850868 hasConcept C2780868878 @default.
- W2090850868 hasConcept C2781034427 @default.
- W2090850868 hasConcept C2781074509 @default.
- W2090850868 hasConcept C54355233 @default.
- W2090850868 hasConcept C86803240 @default.
- W2090850868 hasConceptScore W2090850868C104317684 @default.